Aurora Cannabis (ACB) Equity Income (2018 - 2019)

Aurora Cannabis (ACB) posted quarterly Equity Income of $24.8 million for Q1 2019, up 1966.08% year-on-year from $1.2 million in Q1 2018, and up 1966.08% on a QoQ basis from -$1.3 million in Q1 2018.

Aurora Cannabis (ACB) Equity Income (2018 - 2019) Analysis & Trends

Aurora Cannabis (ACB) has reported Equity Income for 2 consecutive years, with $24.8 million the latest figure, recorded in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2019 24.77 Mn
Mar 31, 2018 -1.33 Mn